Vital KSK Holdings, Inc.

Tokyo Stock Exchange 3151.T

Vital KSK Holdings, Inc. EBITDA Margin for the year ending March 31, 2024: 2.07%

Vital KSK Holdings, Inc. EBITDA Margin is 2.07% for the year ending March 31, 2024, a 106.09% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Vital KSK Holdings, Inc. EBITDA Margin for the year ending March 31, 2023 was 1.00%, a -4.47% change year over year.
Vital KSK Holdings, Inc. EBITDA Margin for the year ending March 31, 2022 was 1.05%, a 501.42% change year over year.
Vital KSK Holdings, Inc. EBITDA Margin for the year ending March 31, 2021 was 0.17%, a -86.37% change year over year.
Vital KSK Holdings, Inc. EBITDA Margin for the year ending March 31, 2020 was 1.28%, a -37.78% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 3151.T

Vital KSK Holdings, Inc.

CEO	Mr. Taisuke Murai
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-1-12, Tsurumaki
Employees	3,705
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Automotive Parts Cleaning Supplies Eyewear Insurance Personal Care Pharmaceuticals Tobacco

Description

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years